Chinese herbal medicine may improve outcomes after STEMI
Por um escritor misterioso
Descrição
CHICAGO — A drug derived from traditional Chinese medicine as an adjunct to guideline-directed therapy improved CV outcomes at 30 days and 1 year compared with placebo after revascularization, with no excess bleeding risk, a speaker reported.“Despite reperfusion and optimal medical therapy, patients with STEMI still face a high risk of in-hospital mortality, myocardial no-flow and
The Pet Oncologist - Vet Oncologist Online - Chinese Herbs. Can It Treat Cancer In Dogs?
The traditional Chinese medicine that could become 'key treatment' for heart attacks, as study finds it lowers inflammation without adverse effects
Signaling pathways and targeted therapy for myocardial infarction
GW25-e0861 Danhong Injection Antagonizes Adriamycin-Induced Cardiotoxicity from Oxidative Stress: Mechanism in vivo and in vitro
China is encouraging herbal remedies to treat COVID-19. But scientists warn against it.
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary
Machine learning enhances the performance of short and long-term mortality prediction model in non-ST-segment elevation myocardial infarction
Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction
Frontiers Chinese herbal injection for cardio-cerebrovascular disease: Overview and challenges
Chinese Medicine Tongxinluo Yields 'Surprising' Benefits Post-STEMI: CTS-AMI
Jade Star Acupuncture & Wellness
de
por adulto (o preço varia de acordo com o tamanho do grupo)
